Backer Marianne De - Net Worth and Insider Trading

Backer Marianne De Net Worth

The estimated net worth of Backer Marianne De is at least $7 Million dollars as of 2024-11-05. Backer Marianne De is the CEO of Vir Biotechnology Inc and owns about 678,457 shares of Vir Biotechnology Inc (VIR) stock worth over $6 Million. Backer Marianne De is the Director of Arrowhead Pharmaceuticals Inc and owns about 17,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $339,320. Backer Marianne De is also the Director of Kronos Bio Inc and owns about 2,750 shares of Kronos Bio Inc (KRON) stock worth over $2,571. Details can be seen in Backer Marianne De's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Backer Marianne De has not made any transactions after 2024-04-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Backer Marianne De

To

Backer Marianne De Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Backer Marianne De owns 3 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , Kronos Bio Inc (KRON) , and Vir Biotechnology Inc (VIR) .

Click here to see the complete history of Backer Marianne De’s form 4 insider trades.

Insider Ownership Summary of Backer Marianne De

Ticker Comapny Transaction Date Type of Owner
ARWR Arrowhead Pharmaceuticals Inc 2022-01-03 director
KRON Kronos Bio Inc 2021-12-01 director
VIR Vir Biotechnology Inc 2024-04-03 Chief Executive Officer

Backer Marianne De Latest Holdings Summary

Backer Marianne De currently owns a total of 3 stocks. Among these stocks, Backer Marianne De owns 678,457 shares of Vir Biotechnology Inc (VIR) as of April 3, 2024, with a value of $6 Million and a weighting of 95%. Backer Marianne De owns 17,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 3, 2022, with a value of $339,320 and a weighting of 4.97%. Backer Marianne De also owns 2,750 shares of Kronos Bio Inc (KRON) as of December 1, 2021, with a value of $2,571 and a weighting of 0.04%.

Latest Holdings of Backer Marianne De

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VIR Vir Biotechnology Inc 2024-04-03 678,457 9.57 6,489,441
ARWR Arrowhead Pharmaceuticals Inc 2022-01-03 17,000 19.96 339,320
KRON Kronos Bio Inc 2021-12-01 2,750 0.94 2,571

Holding Weightings of Backer Marianne De


Backer Marianne De Form 4 Trading Tracker

According to the SEC Form 4 filings, Backer Marianne De has made a total of 1 transactions in Vir Biotechnology Inc (VIR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Vir Biotechnology Inc is the sale of 72,995 shares on April 3, 2024, which brought Backer Marianne De around $690,533.

According to the SEC Form 4 filings, Backer Marianne De has made a total of 4 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 4,500 shares on January 3, 2022, which brought Backer Marianne De around $291,195.

According to the SEC Form 4 filings, Backer Marianne De has made a total of 2 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Kronos Bio Inc is the acquisition of 1,150 shares on December 1, 2021, which cost Backer Marianne De around $13,306.

Insider Trading History of Backer Marianne De

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Backer Marianne De Trading Performance

GuruFocus tracks the stock performance after each of Backer Marianne De's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Backer Marianne De is 3.22%. GuruFocus also compares Backer Marianne De's trading performance to market benchmark return within the same time period. The performance of stocks bought by Backer Marianne De within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Backer Marianne De's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Backer Marianne De

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 30.23 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 27.54 LIMIT LIMIT LIMIT LIMIT LIMIT

Backer Marianne De Ownership Network

Ownership Network List of Backer Marianne De

No Data

Ownership Network Relation of Backer Marianne De

Insider Network Chart

Backer Marianne De Owned Company Details

What does Arrowhead Pharmaceuticals Inc do?

Who are the key executives at Arrowhead Pharmaceuticals Inc?

Backer Marianne De is the director of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include Chief Commercial Officer Tracie Oliver , other: Senior Vice President James C Hamilton , and CFO Kenneth Allen Myszkowski .

Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary

Over the past 18 months, Backer Marianne De made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 161,544 shares made by Christopher Richard Anzalone , a net sale of 55,383 shares made by James C Hamilton , and a net sale of 71,104 shares made by Kenneth Allen Myszkowski .

In summary, during the past 3 months, insiders sold 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 385,678 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 382,678 shares.

Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arrowhead Pharmaceuticals Inc Insider Transactions

No Available Data

Backer Marianne De Mailing Address

Above is the net worth, insider trading, and ownership report for Backer Marianne De. You might contact Backer Marianne De via mailing address: 177 E Colorado Blvd, Suite 700, Pasadena Ca 91105.